Age-specific risk of malignancy in pediatric thyroid cytology: Reframing ROM based on pre-test probability
The Journal of Clinical Endocrinology & Metabolism · 15.07.2026 · 111 (8) · 2367-2377
DOI: 10.1210/clinem/dgag073 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 25.02.2026. Verfasst von Sule Canberk und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of Medicine, RISE-Health, University of Porto (FMUP), 4200-319 Porto, Portugal. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroid Nodule, Thyroid Gland. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Children's Hospital of Philadelphia Frontier Program, The Children’s Hospital of Philadelphia Frontier Program.
Abstract (Originalsprache)
Objective
Pediatric thyroid nodules are uncommon but have a higher malignancy rate than adult nodules. Existing Bethesda risk-of-malignancy (ROM) estimates are not age-stratified and are affected by verification bias. We aimed to generate age-specific ROM, likelihood ratios (LRs), and post-test malignancy probabilities for pediatric and young adult thyroid cytology.
Methods
We analysed 2728 thyroid fine-needle aspirations (FNAs) from patients aged 0-25 years across multiple tertiary centers (2000-2023). All cases were classified or reclassified using the 2023 Bethesda System and grouped into four age bands (0-8, 9-14, 15-18, and 19-25 years). We calculated lower-bound ROM (ROM overall; assuming nonoperated FNAs were benign) and surgery-only upper-bound ROM (ROM surgery; 991 of 2728 cases with histology). Age-specific pretest probabilities and Bethesda-category LRs were used to compute post-test malignancy probabilities with Bayes’ theorem.
Results
Among operated nodules, malignancy prevalence decreased with age (84.2% at 0-8 years to 64.6% at 19-25 years). Verification bias was substantial: malignancy prevalence was 24.6% (671/2728) under the lower-bound assumption but 67.7% (671/991) among surgical cases. Upper-bound ROM values were 2-10 times higher than lower-bound values across categories. Benign cytology showed low LRs (0.07-0.15), reducing post-test malignancy probability to 0-25%. Indeterminate categories showed age-related variation; for example, a follicular neoplasm diagnosis carried a ∼71% post-test risk in a 9-year-old versus ∼49% in a 24-year-old. AUS subtyping (nuclear vs other atypia) did not consistently separate ROM.
Conclusion
Age substantially modifies both pretest and post-test malignancy probabilities in pediatric thyroid cytology. An age-stratified LR framework helps quantify verification bias and provides individualized risk estimates to guide decisions about surgery, molecular testing, and follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Faculty of Medicine, RISE-Health, University of Porto (FMUP), 4200-319 Porto, Portugal.
- Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Division of Endocrinology and Diabetes, The Thyroid Center, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
- Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.
- Department of Pathology, Unidade Local de Saúde de São João, 4200-319 Porto, Portugal.
- Department of Biostatistics, Istanbul Medical Faculty, Basic Medical Sciences, 34093 Istanbul, Türkiye.
ORCID-Profile: Sule Canberk
Förderung
- The Children's Hospital of Philadelphia Frontier Program
- The Children’s Hospital of Philadelphia Frontier Program
Zitieren
APA
Canberk, S., Baloch, Z. W., Isaza, A., Bojarsky, M., Vigliar, E., Carillo, A. M., Dello Iacovo, F., Bellevicine, C., Troncone, G., Simplício, M., Barroca, H., Akkoyunlu, S. Z., Günver, M. G., Rodrigues, E., Capela, J., Weiss, V. L., Wang, H., Aydin, O., Thodou, E., …, & Bauer, A. J. (2026). Age-specific risk of malignancy in pediatric thyroid cytology: Reframing ROM based on pre-test probability. The Journal of Clinical Endocrinology & Metabolism, 111(8), 2367-2377. https://doi.org/10.1210/clinem/dgag073
Vancouver
Canberk S, Baloch ZW, Isaza A, Bojarsky M, Vigliar E, Carillo AM, et al. Age-specific risk of malignancy in pediatric thyroid cytology: Reframing ROM based on pre-test probability. The Journal of Clinical Endocrinology & Metabolism. 2026;111(8):2367-2377. doi:10.1210/clinem/dgag073
BibTeX
@article{Canberk2026,
author = {Canberk, Sule and Baloch, Zubair W and Isaza, Amber and Bojarsky, Mya and Vigliar, Elena and Carillo, Anna Maria and Dello Iacovo, Filippo and Bellevicine, Claudio and Troncone, Giancarlo and Simplício, Mariana and Barroca, Helena and Akkoyunlu, Serra Zeynep and Günver, Mehmet Güven and Rodrigues, Elisabete and Capela, João and Weiss, Vivian L and Wang, Huiying and Aydin, Ozlem and Thodou, Eleni and Gücer, Hasan and Schmitt, Fernando and Bauer, Andrew J},
title = {Age-specific risk of malignancy in pediatric thyroid cytology: Reframing ROM based on pre-test probability},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
volume = {111},
number = {8},
pages = {2367--2377},
doi = {10.1210/clinem/dgag073}
}
EUVIMED